(Q22009356)

GOA release 2020-03-11

NAD binding

1 reference

GOA release 2020-03-11

H Zhou

1

H

Zhou

1 reference

PubMed

PubMed publication ID

10198228

7 February 2023

H H Tai

series ordinal

2

author given names

H H

author last names

Tai

1 reference

PubMed

PubMed publication ID

10198228

Biochemical and Biophysical Research Communications

7 February 2023

language of work or name

English

0 references

publication date

13 April 1999

0 references

published in

0 references

volume

257

0 references

issue

2

0 references

page(s)

414-7

0 references

cites work

Cysteine 182 is essential for enzymatic activity of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

Site-directed mutagenesis of the conserved serine 138 of human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase to an alanine results in an inactive enzyme.

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

Three-dimensional model of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase and relationships to the NADP(+)-dependent enzyme (carbonyl reductase)

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

Adding a positive charge at residue 46 of Drosophila alcohol dehydrogenase increases cofactor specificity for NADP+.

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

Sequence analysis of steroid- and prostaglandin-metabolizing enzymes: application to understanding catalysis.

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

Bacterial expression and site-directed mutagenesis of two critical residues (tyrosine-151 and lysine-155) of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

15-Hydroxyprostaglandin dehydrogenase

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

Eicosanoids and asthma: an update

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

The refined three-dimensional structure of 3 alpha,20 beta-hydroxysteroid dehydrogenase and possible roles of the residues conserved in short-chain dehydrogenases

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

Structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase at 2.20 A resolution

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

Short-chain dehydrogenases/reductases (SDR)

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

Crystal structures of the binary and ternary complexes of 7 alpha-hydroxysteroid dehydrogenase from Escherichia coli

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

Crystal structure of rat liver dihydropteridine reductase

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

Structural and mechanistic characteristics of dihydropteridine reductase: a member of the Tyr-(Xaa)3-Lys-containing family of reductases and dehydrogenases

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

15-Hydroxy-prostanoate dehydrogenase. Prostaglandins as substrates and inhibitors

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021

Mass determination of 15-hydroxyprostaglandin dehydrogenase from human placenta and kinetic studies with (5Z, 8E, 10E, 12S)-12-hydroxy-5,8,10-heptadecatrienoic acid as substrate

1 reference

https://api.crossref.org/works/10.1006%2FBBRC.1999.0356

7 January 2021